Adapting Clinical Practice to a Rapidly Changing Therapeutic Landscape in Multiple Myeloma

Download All
In this comprehensive program centered on an in-person and online live CCO symposium at ASH 2021, experts discuss recent developments in management of multiple myeloma. Review their insights in clinical commentaries, along with an on-demand webcast and downloadable slides from the symposium. In addition, listen to the audio podcast to hear the experts answer audience questions and download a treatment algorithm to use in your clinic.
Brian G.M. Durie, MD
Program Director
Brian G.M. Durie, MD
Thomas G. Martin, MD
Philippe Moreau, MD
S. Vincent Rajkumar, MD
Jesús F. San-Miguel, MD, PhD

Podcast

In this podcast episode, listen to Brian G.M. Durie, MD; Thomas G. Martin, MD; Philippe Moreau, MD; S. Vincent Rajkumar, MD; and Jesús F. San-Miguel, MD, PhD, discuss management of patients with multiple myeloma from a recent symposium during the annual hematology meeting in 2021.

Brian G.M. Durie, MD Thomas G. Martin, MD Philippe Moreau, MD S. Vincent Rajkumar, MD Jesús F. San-Miguel, MD, PhD Released: February 18, 2022

In these notes from a podcast, read how Brian G.M. Durie, MD; Thomas G. Martin, MD; Philippe Moreau, MD; S. Vincent Rajkumar, MD; and Jesús F. San-Miguel, MD, PhD, discussed management of patients with multiple myeloma from a recent symposium during the annual hematology meeting in 2021.

Brian G.M. Durie, MD
Program Director
Thomas G. Martin, MD Philippe Moreau, MD S. Vincent Rajkumar, MD Jesús F. San-Miguel, MD, PhD
Released: February 23, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Supported by educational grants from
Bristol-Myers Squibb
Genentech, a member of the Roche Group
GlaxoSmithKline
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Karyopharm Therapeutics
Oncopeptides
Pfizer, Inc.
Sanofi Genzyme

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings